Y-Intercept (HK)’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-127,780
Closed -$1.39M 2033
2026
Q1
$1.39M Sell
127,780
-25,738
-17% -$321K 0.03% 897
2025
Q4
$1.98M Buy
+153,518
New +$1.97M 0.04% 626
2025
Q3
Sell
-21,727
Closed -$387K 1892
2025
Q2
$387K Sell
21,727
-1,765
-8% -$30.8K 0.01% 1285
2025
Q1
$419K Buy
23,492
+4,723
+25% +$107K 0.03% 778
2024
Q4
$559K Buy
+18,769
New +$397K 0.04% 676
2024
Q2
Sell
-123,939
Closed -$1.94M 1757
2024
Q1
$1.94M Buy
123,939
+56,302
+83% +$828K 0.15% 175
2023
Q4
$1.01M Buy
67,637
+17,254
+34% +$231K 0.09% 317
2023
Q3
$814K Buy
+50,383
New +$1.45M 0.08% 380
2022
Q1
Sell
-5,248
Closed -$394K 880
2021
Q4
$394K Sell
5,248
-775
-13% -$77.8K 0.09% 316
2021
Q3
$700K Buy
+6,023
New +$911K 0.13% 249
2021
Q2
Sell
-6,239
Closed -$781K 810
2021
Q1
$781K Buy
+6,239
New +$987K 0.21% 148

Other funds holding NVCR